Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Vincent, Javinal"'
Autor:
Johannes Riegler, Herman Gill, Annie Ogasawara, Maj Hedehus, Vincent Javinal, Jason Oeh, Gregory Z. Ferl, Jan Marik, Simon Williams, Deepak Sampath, Jill Schartner, Richard A.D. Carano
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 10, Pp 1036-1050 (2019)
Cancer immunotherapies have demonstrated durable responses in a range of different cancers. However, only a subset of patients responds to these therapies. We set out to test if non-invasive imaging of tumor perfusion and vascular inflammation may be
Externí odkaz:
https://doaj.org/article/741a375fc66146b38b3c4feb55c71ce8
Autor:
Shravan Kumar Sriraman, Christopher W. Davies, Herman Gill, James R. Kiefer, Jianping Yin, Annie Ogasawara, Alejandra Urrutia, Vincent Javinal, Zhonghua Lin, Dhaya Seshasayee, Ryan Abraham, Phil Haas, Christopher Koth, Jan Marik, James T. Koerber, Simon Peter Williams
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 50:679-691
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f089c094378cad1bc4da07510270b743
https://doi.org/10.1007/s00259-022-05998-0
https://doi.org/10.1007/s00259-022-05998-0
Autor:
Janet Lau, Jeanne Cheung, Armando Navarro, Steve Lianoglou, Benjamin Haley, Klara Totpal, Laura Sanders, Hartmut Koeppen, Patrick Caplazi, Jacqueline McBride, Henry Chiu, Rebecca Hong, Jane Grogan, Vincent Javinal, Robert Yauch, Bryan Irving, Marcia Belvin, Ira Mellman, Jeong M. Kim, Maike Schmidt
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-11 (2017)
PD-L1, the ligand for T-cell inhibitory receptor PD-1, can be expressed by various cell types in the tumour microenvironment. Here, the authors show that, in mouse models, the expression of PD-L1 from both cancerous and normal host immune cells is im
Externí odkaz:
https://doaj.org/article/1afbaeea25fd48089e499f52e8e8af6d
Autor:
Mathias Vormehr, Sophie Lehar, Lena M. Kranz, Siri Tahtinen, Yoko Oei, Vincent Javinal, Lélia Delamarre, Kerstin C. Walzer, Mustafa Diken, Sebastian Kreiter, Ira Mellman, Ugur Sahin, Jill M. Schartner, Özlem Türeci
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Glucocorticosteroids (GCS) have an established role in oncology and are administered to cancer patients in routine clinical care and in drug development trials as co-medication. Given their strong immune-suppressive activity, GCS may interfere with i
Externí odkaz:
https://doaj.org/article/8226105be4244dba8929cab8e349dfef
Autor:
Kevin B. Walsh, Jeong M. Kim, Jovencio Borneo, Vincent Javinal, Aurelie Herault, Rajiv Jesudason, Genevive Hernandez, Judy Mak, Patricia E. de Almeida
Antiangiogenic therapies that target the VEGF pathway have been used clinically to combat cancer for over a decade. Beyond having a direct impact on blood vessel development and tumor perfusion, accumulating evidence indicates that these agents also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::235e4e725cc5aa297c65f359b53e0f02
https://doi.org/10.1158/2326-6066.c.6550410
https://doi.org/10.1158/2326-6066.c.6550410
Autor:
Kevin B. Walsh, Jeong M. Kim, Jovencio Borneo, Vincent Javinal, Aurelie Herault, Rajiv Jesudason, Genevive Hernandez, Judy Mak, Patricia E. de Almeida
Supplementary tables 1-4 and supplementary figures 1-8.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95c71a4032796d19e9a2c56f6d9a9408
https://doi.org/10.1158/2326-6066.22543803.v1
https://doi.org/10.1158/2326-6066.22543803.v1
Autor:
Richard A.D. Carano, Jill Schartner, Shannon J. Turley, Melissa R. Junttila, Wendy Sandoval, Qingling Li, Jason E. Long, Claudia X. Dominguez, Alessandra Castiglioni, Vincent Javinal, Stephen Rosenzweig, Yassin Labyed, Johannes Riegler
Supplementary methods, supplementary figures and tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d86fe0320ee33e988253e30360d88c
https://doi.org/10.1158/1078-0432.22469681
https://doi.org/10.1158/1078-0432.22469681
Autor:
Richard A.D. Carano, Jill Schartner, Shannon J. Turley, Melissa R. Junttila, Wendy Sandoval, Qingling Li, Jason E. Long, Claudia X. Dominguez, Alessandra Castiglioni, Vincent Javinal, Stephen Rosenzweig, Yassin Labyed, Johannes Riegler
Purpose: The tumor microenvironment presents with altered extracellular matrix (ECM) and stroma composition, which may affect treatment efficacy and contribute to tissue stiffness. Ultrasound (US) elastography can visualize and quantify tissue stiffn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232306ec8803051904df3a1d04950716
https://doi.org/10.1158/1078-0432.c.6527312
https://doi.org/10.1158/1078-0432.c.6527312
Autor:
Shravan Kumar, Sriraman, Christopher W, Davies, Herman, Gill, James R, Kiefer, Jianping, Yin, Annie, Ogasawara, Alejandra, Urrutia, Vincent, Javinal, Zhonghua, Lin, Dhaya, Seshasayee, Ryan, Abraham, Phil, Haas, Christopher, Koth, Jan, Marik, James T, Koerber, Simon Peter, Williams
Publikováno v:
European journal of nuclear medicine and molecular imaging.
Cancer immunotherapies (CITs) have revolutionized the treatment of certain cancers, but many patients fail to respond or relapse from current therapies, prompting the need for new CIT agents. CD8To this end, we discovered and developed a 13-kDa singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9afa9b240811f5c84d5d69908a699efe
https://pubmed.ncbi.nlm.nih.gov/36346438
https://pubmed.ncbi.nlm.nih.gov/36346438
Autor:
Kevin Walsh, Aurelie Herault, Genevive Hernandez, Patrícia de Almeida, Judy Mak, Jeong M. Kim, Rajiv Jesudason, Vincent Javinal, Jovencio Borneo
Publikováno v:
Cancer Immunology Research. 8:806-818
Antiangiogenic therapies that target the VEGF pathway have been used clinically to combat cancer for over a decade. Beyond having a direct impact on blood vessel development and tumor perfusion, accumulating evidence indicates that these agents also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bc6b07a7032555f678c5771e7435df3
https://doi.org/10.1158/2326-6066.cir-19-0360
https://doi.org/10.1158/2326-6066.cir-19-0360